tirzepatide dosage vs semaglutide and Charts: A Complete Guide Switching between weight-loss medications -
Description
It was developed for a once-weekly diabetes therapy and its clinical trials started in 2016, ending in 2017, after which it was approved by the U.S
They share a mechanism both are growth hormone-releasing hormone (GHRH) analogs that stimulate your pituitary gland to produce more of its own GH but the intensity, clinical profile, and ideal use case for each are meaningfully different
J Biol Chem 278 , 2305523065 (2003)
For a comparison of those two, see our semaglutide vs tirzepatide breakdown
